These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5415045)

  • 21. Immunobiological relationships of the enterotoxins produced by cholera toxin gene-positive (CT+) and -negative (CT-) strains of Vibrio cholerae O1.
    Saha S; Sanyal SC
    J Med Microbiol; 1990 May; 32(1):33-7. PubMed ID: 2342085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reaction of Vibrio cholerae and choleragenic toxin in ileal loop of laboratory animals.
    Basu S; Pickett MJ
    J Bacteriol; 1969 Nov; 100(2):1142-3. PubMed ID: 5359618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AGGLUTINATING, LETHAL TOXIN AND E1 TOR HAEMOLYSIN NEUTRALIZING POTENCY OF SERA IN CHOLERA.
    FELSENFELD O; NASUNIYA N; WATANABE Y; PENA A; DALE BN
    Bull World Health Organ; 1964; 30(6):833-44. PubMed ID: 14215189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunobiological relationships among new cholera toxins produced by CT gene-negative strains of Vibrio cholerae O1.
    Saha S; Sanyal SC
    J Med Microbiol; 1989 Jan; 28(1):33-7. PubMed ID: 2492345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of bacterial adhesion in the pathogenesis of cholera.
    Chitnis DS; Sharma KD; Kamat RS
    J Med Microbiol; 1982 Feb; 15(1):43-51. PubMed ID: 7143425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serological studies in cholera. 3. Serum toxin neutralization--rise in titre in response to infection with Vibrio cholerae, and the level in the "normal" population of East Pakistan.
    Benenson AS; Saad A; Mosley WH; Ahmed A
    Bull World Health Organ; 1968; 38(2):287-95. PubMed ID: 5302304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Separation of type 2 toxins of Vibrio cholerae.
    Lewis AC; Freeman BA
    Science; 1969 Aug; 165(3895):808-9. PubMed ID: 5804723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological activities of enterotoxin from Vibrio cholerae non-01.
    Hostacká A; Ciznár I; Korych B; Karolcek J
    J Hyg Epidemiol Microbiol Immunol; 1983; 27(2):189-95. PubMed ID: 6193168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological similarity of enterotoxins of Vibrio cholerae serotypes other than type 1 to cholera toxin and Escherichia coli heat-labile enterotoxin.
    Lahiri A; Agarwal RK; Sanyal SC
    J Med Microbiol; 1982 Nov; 15(4):429-40. PubMed ID: 6757437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Titration of cholera antitoxin in human sera by microhemagglutination with formalinized erythrocytes.
    Hochstein HD; Feeley JC; DeWitt WE
    Appl Microbiol; 1970 May; 19(5):742-5. PubMed ID: 5463574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Some observations on the neutralization of cholera vascular permeability factor in vivo.
    Craig JP
    J Infect Dis; 1970 May; 121():Suppl 121:100+. PubMed ID: 5421424
    [No Abstract]   [Full Text] [Related]  

  • 32. Cholera toxin and toxoid.
    Ungar J; Stanić M; Chariatte N; Varallyay SJ
    Prog Immunobiol Stand; 1971; 5():348-9. PubMed ID: 4660540
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect on enterotoxicity of protease purified from Vibrio cholerae O1.
    Ichinose Y; Ehara M; Honda T; Miwatani T
    FEMS Microbiol Lett; 1994 Jan; 115(2-3):265-71. PubMed ID: 8138138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fixation and inactivation of cholera toxin by GM1 ganglioside.
    Holmgren J; Lönnroth I; Svennerholm L
    Scand J Infect Dis; 1973; 5(1):77-8. PubMed ID: 4199382
    [No Abstract]   [Full Text] [Related]  

  • 35. The antibody basis of local immunity to experimental cholera infection in the rabbit ileal loop.
    Burrows W; Kaur J
    Prog Drug Res; 1975; 19():471-80. PubMed ID: 1219901
    [No Abstract]   [Full Text] [Related]  

  • 36. Subunit structure of cholera toxin.
    Lönnroth I; Holmgren J
    J Gen Microbiol; 1973 Jun; 76(2):417-27. PubMed ID: 4198716
    [No Abstract]   [Full Text] [Related]  

  • 37. Magnitude and duration of antitoxic response to human infection with Vibrio cholerae.
    Pierce NF; Banwell JG; Sack RB; Mitra RC; Mondal A
    J Infect Dis; 1970 May; 121():Suppl 121:31+. PubMed ID: 5421427
    [No Abstract]   [Full Text] [Related]  

  • 38. Attempt to characterize choleragenic fraction and the skin permeability factor from vibrio culture filtrates as separate indentity.
    Chatterjee PK; Rao SS; Dutta NK
    Indian J Med Res; 1972 Nov; 60(11):1568-74. PubMed ID: 4654627
    [No Abstract]   [Full Text] [Related]  

  • 39. Deactivation of cholera toxin by a sialidase-resistant monosialosylganglioside.
    King CA; Van Heyningen WE
    J Infect Dis; 1973 Jun; 127(6):639-47. PubMed ID: 4707310
    [No Abstract]   [Full Text] [Related]  

  • 40. Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine.
    Cash RA; Music SI; Libonati JP; Craig JP; Pierce NF; Hornick RB
    J Infect Dis; 1974 Oct; 130(4):325-33. PubMed ID: 4443613
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.